AGTX
Agentix Corp. [AGTX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AGTX Stock Summary
In the News
AGTX Financial details
Company Rating
Sell
Market Cap
1.29M
Income
-1.53M
Revenue
0
Book val./share
-0.07
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
14 Feb 2024
P/E
-0.81
Forward P/E
-
PEG
0.09
P/S
-
P/B
-0.47
P/C
-
P/FCF
-8.21
Quick Ratio
-
Current Ratio
0.11
Debt / Equity
-0.04
LT Debt / Equity
-
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-91.03%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-78.07%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
13.33%
-
-
-
-
SMA20
66.67%
SMA50
66.67%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-462%
ROE
73%
ROC
0.58%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0301-0.129
52W High
-
52W Low
-
RSI
23.42
Rel Volume
0.97
Avg Volume
1.3K
Volume
1.26K
Perf Week
-35.6%
Perf Month
3.87%
Perf Quarter
-
Perf Half Y
-54.65%
-
-
-
-
Beta
-1.497
-
-
Volatility
0.01%, 0.01%
Prev Close
0.31%
Price
0.0322
Change
0.31%
AGTX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2018-08-31 | 2019-08-31 | 2020-08-31 | 2021-08-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -7.74K | -0.07 | 0 | -0.39 | -0.04 | |
| Operating cash flow per share | -4.67 | -0.03 | 0 | -0.12 | 0 | |
| Free cash flow per share | -4.67 | -0.03 | 0 | -0.12 | 0 | |
| Cash per share | 0.19 | 0 | 0 | 0.07 | 0 | |
| Book value per share | -4.81 | 0 | 0 | 0.07 | -0.06 | |
| Tangible book value per share | -4.81 | 0 | 0 | 0.07 | -0.06 | |
| Share holders equity per share | -4.81 | 0 | 0 | 0.07 | -0.06 | |
| Interest debt per share | 6.39 | 0 | 0 | 0.01 | 0 | |
| Market cap | 336.75K | 49.37M | 0 | 2.4M | 3.92M | |
| Enterprise value | 380.37K | 0 | 109.58K | 2.15M | 3.96M | |
| P/E ratio | 0 | -342.86 | 0 | -1.79 | -2.85 | |
| Price to sales ratio | 0 | 0 | 0 | 1.93K | 0 | |
| POCF ratio | -6.53 | -795.85 | 0 | -5.69 | -44.31 | |
| PFCF ratio | -6.53 | -795.85 | 0 | -5.69 | -44.31 | |
| P/B Ratio | -6.34 | 0 | 0 | 10.72 | -1.74 | |
| PTB ratio | -6.34 | 0 | 0 | 10.72 | -1.74 | |
| EV to sales | 0 | 0 | 0 | 1.74K | 0 | |
| Enterprise value over EBITDA | -2.84 | 0 | 0 | -1.61 | -2.89 | |
| EV to operating cash flow | -7.38 | 0 | 0 | -5.11 | -44.73 | |
| EV to free cash flow | -7.38 | 0 | 0 | -5.11 | -44.73 | |
| Earnings yield | -253.66 | 0 | 0 | -0.56 | -0.35 | |
| Free cash flow yield | -0.15 | 0 | 0 | -0.18 | -0.02 | |
| Debt to equity | -0.86 | 0 | -0.87 | 0 | -0.02 | |
| Debt to assets | 20.2 | 0 | 1.18K | 0 | 0.19 | |
| Net debt to EBITDA | -0.33 | 0 | 0 | 0.18 | -0.03 | |
| Current ratio | 0.22 | 0 | 0 | 4.23 | 0.1 | |
| Interest coverage | -5.41 | -10.7 | 0 | -68.69 | -834.91 | |
| Income quality | 0 | 0.47 | 0 | 0.31 | 0.06 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 787.02 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 294.46 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 915.25 | 0 | 0 | 0.76 | 0.21 | |
| ROIC | 36.32 | 0 | 0 | -6.09 | 0.62 | |
| Return on tangible assets | -37.71K | 0 | 0 | -4.58 | -5.26 | |
| Graham Net | -4.83 | 0 | 0 | 0.05 | -0.06 | |
| Working capital | -7.53K | 0 | -40.79K | 223.46K | -2.25M | |
| Tangible asset value | -53.13K | 0 | -125.79K | 223.46K | -2.25M | |
| Net current asset value | -53.27K | 0 | -125.79K | 223.46K | -2.25M | |
| Invested capital | -0.86 | 0 | -0.87 | 0 | -0.02 | |
| Average receivables | 6.61K | 0 | 0 | -24.72K | 0 | |
| Average payables | 5.42K | 0 | 0 | 40.84K | 0 | |
| Average inventory | 0 | 0 | 0 | 24.72K | 0 | |
| Days sales outstanding | 0 | 0 | 0 | -14.55K | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 45.02K | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 32.17K | 0 | |
| Receivables turnover | 0 | 0 | 0 | -0.03 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0.01 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0.01 | 0 | |
| ROE | 1.61K | 0 | 0 | -6 | 0.61 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q1
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | -0.03 | -0.04 | -0.05 | -0.06 | -0.07 | |
| Tangible book value per share | -0.03 | -0.04 | -0.05 | -0.06 | -0.07 | |
| Share holders equity per share | -0.03 | -0.04 | -0.05 | -0.06 | -0.07 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 5.84M | 4.49M | 6.63M | 3.91M | 2.8M | |
| Enterprise value | 5.84M | 4.49M | 6.63M | 3.95M | 2.9M | |
| P/E ratio | -8.86 | -2.64 | -4.89 | -2.77 | -1.71 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 132.67K | -94.52 | 32.82K | -94.71 | -44.69 | |
| PFCF ratio | 132.67K | -94.52 | 32.82K | -94.71 | -44.69 | |
| P/B Ratio | -4.7 | -2.78 | -3.56 | -1.74 | -1.06 | |
| PTB ratio | -4.7 | -2.78 | -3.56 | -1.74 | -1.06 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -35.45 | -10.57 | -18.75 | -11.17 | -7.23 | |
| EV to operating cash flow | 132.67K | -94.46 | 32.82K | -95.63 | -46.19 | |
| EV to free cash flow | 132.67K | -94.46 | 32.82K | -95.63 | -46.19 | |
| Earnings yield | -0.03 | -0.09 | -0.05 | -0.09 | -0.15 | |
| Free cash flow yield | 0 | -0.01 | 0 | -0.01 | -0.02 | |
| Debt to equity | 0 | 0 | 0 | -0.02 | -0.04 | |
| Debt to assets | 0 | 0 | 0 | 0.19 | 0.3 | |
| Net debt to EBITDA | 0 | 0.01 | 0 | -0.11 | -0.23 | |
| Current ratio | 0.01 | 0.01 | 0.06 | 0.1 | 0.11 | |
| Interest coverage | 0 | 0 | 23.58 | 0 | -78.96 | |
| Income quality | 0 | 0.11 | 0 | 0.1 | 0.15 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.06 | 0.1 | 0.1 | 0.11 | 0.12 | |
| ROIC | 0.13 | 0.26 | 0.18 | 0.16 | 0.16 | |
| Return on tangible assets | -14.94 | -49.72 | -3.04 | -1.35 | -1.24 | |
| Graham Net | -0.03 | -0.04 | -0.05 | -0.06 | -0.07 | |
| Working capital | -1.24M | -1.62M | -1.86M | -2.25M | -2.65M | |
| Tangible asset value | -1.24M | -1.62M | -1.86M | -2.25M | -2.65M | |
| Net current asset value | -1.24M | -1.62M | -1.86M | -2.25M | -2.65M | |
| Invested capital | 0 | 0 | 0 | -0.02 | -0.04 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 1.15M | 1.44M | 1.8M | 2.21M | 2.66M | |
| Average inventory | 24.72K | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.13 | 0.26 | 0.18 | 0.16 | 0.15 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
AGTX Frequently Asked Questions
What is Agentix Corp. stock symbol ?
Agentix Corp. is a US stock , located in Dana point of Ca and trading under the symbol AGTX
What is Agentix Corp. stock quote today ?
Agentix Corp. stock price is $0.0322 today.
Is Agentix Corp. stock public?
Yes, Agentix Corp. is a publicly traded company.
Company Profile
- Volume Average 1.3K
- Market Capitalization 1.29M
- CEO Mr. Salman Hoda
- Headquarters Dana Point,CA,US
- IPO Date 2015-08-21
-
Website
https://www.agentixcorp.com 
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of therapeutics to treat metabolic diseases. Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was incorporated in 2013 and is based in Dana Point, California.
